Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites: Effects in patients with organic or functional renal failure

Scandinavian Journal of Gastroenterology

Volumn 35, Issue 6, 2000, Pages 654-658

  Michl, P ^a   Gulberg V ^a   Bilzer, M ^a   Waggershauser, T ^a   Reiser, M ^a   Gerbes, Alexander L ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Chronic renal failure; Function; Liver

Indexed keywords

CREATININE; UREA;

ADULT; AGED; ARTICLE; ASCITES; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; FEMALE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER CIRRHOSIS; MALE; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME; UREA BLOOD LEVEL;

EID: 0033923689     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655200750023642     Document Type: Article

References (19)

1. 1. Gerbes AL, Gülberg V, Waggershauser T, Holl J, Reiser M. Transjugular intrahepatic portosystemic shunt (TIPS) for variceal bleeding in portal hypertension: comparison of emergency and elective interventions. Dig Dis Sci 1998;43: 2463-9.
2. 2. Rössle M, Deibert P, Haag K, Ochs A, Olschewski M, Siegerstetter V, et al. Randomised trial of transjugular intrahepatic portosystemic shunt versus endoscopy plus propanolol for prevention of variceal rebleeding. Lancet 1997;349: 1043-9.
3. 3. Gerbes AL, Gülberg V, Waggershauser T, Holl J, Reiser M. Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites. Hepatology 1998;28:683-8.
4. 4. Ochs A, Rössle M, Haag K, Hauenstein K-H, Deibert P, Siegerstetter V, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995;332:1192-7.
5. 5. Gines P, Arroyo V, Vargas V, Planas R, Casafont F, Panes J, et al. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 1991;325:829-35.
6. 6. Bories P, Garcia Compean D, Michel H, Bourel M, Capron JP, Gauthier A, et al. The treatment of refractory ascites by the LeVeen shunt: a multicenter controlled trial. J Hepatol 1986;3: 212-8.
7. 7. Somberg K, Lake JR, Tomlanovich SJ, LaBerge JM, Feldstein V, Bass NM. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function. Hepatology 1995;21:709-16.
8. 8. Deschenes M, Dufresne M-P, Bui B, Fenyves D, Spahr L, Roy L, et al. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites. Am J Gastroenterol 1999;94:1361-5.
9. 9. Nazarian GK, Bjarnason H, Dietz CA, Bernadas CA, Foshager MC, Ferral H, et al. Refractory ascites: midterm results of treatment with a transjugular intrahepatic portosystemic shunt. Radiology 1997;205:173-80.
10. 10. Crenshaw WB, Gordon FD, McEniff NJ, Perry LJ, Hartnell G, Anastopoulos H, et al. Severe ascites: efficacy of the transjugular intrahepatic portosystemic shunt in treatment. Radiology 1996;200:185-192.
11. 11. Arroyo V, Gines P, Gerbes AL, Dudley F, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996;23:164-76.
12. 12. Quiroga J, Sangro B, Nunez M, Bilbao I, Longo J, Garcia-Villarreal L, et al. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effects on clinical, renal, humoral, and hemodynamic parameters. Hepatology 1995;21:986-94.
13. 13. Lebrec D, Giuily N, Hadengue A, Vilgrain V, Moreau R, Poynard T, et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. J Hepatol 1996;25:135-44.
14. 14. Eckardt KU. Renal failure in liver disease. Intensive Care Med 1999;25:5-14.
15. 15. Nicholls KM, Shapiro MD, Van Putten VJ, Kluge R, Chung HM, Bichet DG, et al. Elevated plasma norepinephrine concentrations in decompensated cirrhosis: association with increased secretion rates, normal clearance rates and suppressibility by central blood volume expansion. Circ Res 1985;56: 457-61.
16. 16. Wong F, Sniderman K, Liu P, Allindina Y, Sherman M, Blendis L. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Intern Med 1995;122:816-22.
17. 17. Guevara M, Gines P, Bandi JC, Gilabert R, Sort P, Jimenez W, et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology 1998;28:416-22.
18. 18. Ochs A, Rössle M, Haag K, Gerbes AL, Morgenroth A, Deibert P, et al. TIPS for hepatorenal syndrome. Hepatology 1994;20: 114A.
19. 19. Brensing KA, Textor J, Strunk H, Klehr HU, Schild H, Sauerbruch T. Transjugular intrahepatic portosystemic stent -shunt for hepatorenal syndrome. Lancet 1997;349:697-8.